How Does Nipocalimab Work? Understanding This FcRn-Blocking Antibody
•
3 min read
According to research published in the journal *mAbs*, nipocalimab is a fully human monoclonal antibody designed to bind with high affinity to and block the neonatal Fc receptor (FcRn). By doing so, it offers a novel approach to treating autoimmune diseases by reducing the levels of pathogenic immunoglobulin G (IgG) antibodies.
